
    
      This study was designed to assess the pharmacokinetic linearity and comparative
      bioavailability of UT-15C SR (treprostinil diethanolamine) following the administration of a
      single tablet containing 0.5 mg, 1 mg and 2.5 mg UT-15C in healthy volunteers.
    
  